Chemical engineers have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus -- regarded by many as nearly impenetrable -- and carrying medication that could treat a range of diseases.

Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research say.